Cargando…
The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China
BACKGROUND: The high costs of novel anticancer drugs have caused concern among healthcare stakeholders. To address the knowledge gap on the proportion of survival benefit with the related economic expenditure, we aimed to assess the correlation between the costs and value of innovative drugs targete...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Global Health
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629928/ https://www.ncbi.nlm.nih.gov/pubmed/37934965 http://dx.doi.org/10.7189/jogh.13.04140 |